Awards and Rankings
September 9, 2022

Goodwin Lawyers and Practices Honored at the LMG Life Sciences Americas Awards 2022

Several Goodwin lawyers and practices were honored at the LMG Life Sciences Americas Awards 2022, which took place on September 8 in New York City. Now in its tenth year, the LMG Life Sciences Americas Awards recognize the top-ranking lawyers, firms and in-house counsel teams in the United States and Canada who have had a significant impact on the life sciences industry over the past year.

Goodwin was named the FDA Litigation & Enforcement Firm of the Year for 2022. The firm’s FDA Litigation practice works with life sciences companies on pre-litigation strategy before the FDA and leads subsequent litigation efforts. Co-Chaired by partners Brian Burgess and Alexander Varond, the team combines deep subject-matter knowledge with general experience litigating challenges under the Administrative Procedure Act.

Elaine Blais was named the General Patent Litigator of the Year – New England. Blais is the Head of the Litigation Department in Boston and a member of the firm’s Executive Committee. 

Stuart Cable received the Venture Capital Attorney of the Year Award. Cable is Goodwin’s Vice Chairman and Global Chair of M&A. 

Julie Tibbets received the Regulatory Attorney of the Year: FDA Pharmaceutical Award. Tibbets Chairs Goodwin’s FDA practice and is a Co-Chair of the Late-Stage Drug Development practice at the firm.

Goodwin also received the Impact Deal of the Year Award for the firm’s work on Intellia Therapeutics $690 million underwritten public offering, which came on the heels of the company releasing the first-ever clinical data supporting safety and efficacy of in vivo CRISPR genome editing in humans. The Goodwin team advising Intellia included Gabriela Morales-Rivera, Daniel Hughes, Pablo Hernandez-Romero, Janet Andolina, Alexander Varond, and Maggie Wong.

To learn more about Goodwin’s winners and see the full list of results, visit the LMG Life Sciences Americas Awards 2022.